Publications by authors named "Tim H Brummendorf"

Claim this Profile
F
Frequent and clinically relevant germline DNA repair gene variants in young and familial myeloproliferative neoplasms.
Robert Meyer, Maria Jimena Rodriguez, Madeline Caduc, Kim Kricheldorf, Matthias Begemann

Blood Cancer J· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient-centered perspective.
Philipp Ernst, Cera Lohse, Michael Lauseker, Jan Geißler, Philipp le Coutre

Leukemia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NLRP3-induced systemic inflammation controls the development of JAK2V617F mutant myeloproliferative neoplasms.
Ruth-Miriam Koerber, Calvin Krollmann, Kevin Cieslak, Elisabeth Tregel, Maria L Saenz

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients.
Marius Bill, Jan-Niklas Eckardt, Konstanze Döhner, Maximillian-Alexander Röhnert, Christian Rausch

Leukemia· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZIP10 as a potential therapeutic target in acute myeloid leukaemia.
Benjamin Rolles, Nicolas Chatain, Richard Görg, Margherita Vieri, Nora Tillmann-Tröster

Br J Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction chemotherapy with CPX-351 in acute myeloid leukemia: revisiting the role of early bone marrow assessment.
Julian Ronnacker, Leo Ruhnke, Christoph Röllig, Jan Moritz Middeke, Regina Herbst

Leukemia· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic stem cell transplantation from variant-carrying family donors leads to long-term engraftment in Telomere Biology Disorders.
Nergis Güzel, Yannic Schumacher, Kim Kricheldorf, Margherita Vieri, Martin Kirschner

Blood Cancer J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late-onset telomere biology disorders in adults: clinical insights and treatment outcomes from a retrospective registry cohort.
Mareike Tometten, Fabian Beier, Martin Kirschner, Yannic Schumacher, Jeanette Walter

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the complex clonal heterogeneity of polycythemia vera and the response to interferon alfa.
Milena Kalmer, Martin Grasshoff, Tiago Maié, Kristina Pannen, Marcelo A S Toledo

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of recognition of symptom burden in MPN between patient- and physician-reported assessment - an intraindividual analysis by the German Study Group for MPN (GSG-MPN).
Kirsi Manz, Florian H Heidel, Steffen Koschmieder, Rudolf Schlag, Jörg Lipke

Leukemia· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitigation of atrial fibrillation-related complications with antithrombotic and cytoreductive therapy in patients with Myeloproliferative Neoplasms: Implications from the GSG-MPN bioregistry.
Hyunyee Rosa Cho, Susanne Isfort, Kim Kricheldorf, Frank Stegelmann, Martine Klausmann

Hemasphere· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telomere Length Is Associated With Adverse Atrial Remodeling in Patients With Atrial Fibrillation.
Kabita Pradhan, Balram Neupane, Paul Niehues, Martin Kirschner, Fabian Beier

J Am Heart Assoc· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic.
Volker Arndt, Daniela Doege, Stefan Fröhling, Peter Albers, Hana Algül

J Cancer Res Clin Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of body mass index on the safety of bosutinib in patients with chronic leukemia: A post hoc pooled data analysis.
Susanne Isfort, Carlo Gambacorti-Passerini, Tim H Brümmendorf, B Douglas Smith, Simon Purcell

Leuk Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9.
Rebekka K Schneider, Monica Schenone, Monica Ventura Ferreira, Rafael Kramann, Cailin E Joyce

Nat Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy.
Joao Gorgulho, Sven H Loosen, Ramsha Masood, Franziska Giehren, Francesca Pagani

J Exp Clin Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective study on pomalidomide-PACE as a salvage regimen in aggressive relapsed and refractory multiple myeloma.
Deniz Gezer, Melanie Schmitt Nogueira, Martin Kirschner, Tim H Brümmendorf, Carsten Müller-Tidow

Eur J Haematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial.
Carlo Gambacorti-Passerini, Tim H Brümmendorf, Elisabetta Abruzzese, Kevin R Kelly, Vivian G Oehler

Leukemia· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inherited Telomere Biology Disorders: Pathophysiology, Clinical Presentation, Diagnostics, and Treatment.
Benjamin Rolles, Mareike Tometten, Robert Meyer, Martin Kirschner, Fabian Beier

Transfus Med Hemother· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of a complex psychosocial intervention for families with parental cancer: acceptability, suitability, implementability, and perceived support.
Nicole Ernstmann, Hannah Nakata, Lina Heier, Christian Heuser, Marc Dohmen

J Cancer Res Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical considerations in the management of patients treated with bosutinib for chronic myeloid leukemia.
Jeffrey H Lipton, Tim H Brümmendorf, Kendra Sweet, Jane F Apperley, Jorge E Cortes

Ann Hematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens.
David Baden, Sven Zukunft, Gema Hernandez, Nadine Wolgast, Sophie Steinhauser, Tim H Brummendorf

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asciminib antagonizes transplantable BCR::ABL1-positive lymphoid blast crisis in vivo by targeting malignant stem cells.
Nicolas Chatain, Julian Baumeister, Marcelo A Szymanski de Toledo, Dickson W L Wong, Siddharth Gupta

Leukemia· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of bosutinib in patients treated with prior imatinib and/or dasatinib and/or nilotinib: Subgroup analyses from the phase 4 BYOND study.
B Douglas Smith, Tim H Brümmendorf, Gail J Roboz, Carlo Gambacorti-Passerini, Aude Charbonnier

Leuk Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry.
Vikas Bhuria, Tobias Franz, Conny Baldauf, Martin Böttcher, Nicolas Chatain

Cell Commun Signal· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis